Eli Lilly and Company (LLY) is sensitive to: drug approvals, obesity drug demand, earnings, Medicare policy.Major pharma — GLP-1 weight loss drugs (Mounjaro/Zepbound), insulin.

Get LLY alerts before the market moves

AI-powered news filtering. Only what matters to your positions.

Start free trial

Frequently asked questions

What is moving LLY today?

We're adding two new stocks to our Bullpen watchlist.

LLY news and market impact

Latest LLY news

We're adding two new stocks to our Bullpen watchlist.

Where we stand on Broadcom after Marvell muscles in on its key customer Google.

Hims & Hers CEO says FTC lawsuit misunderstands how the company works

What flash memory maker SanDisk told investors this week is a boon for our newest stock.

Here's a rapid-fire update on our 32-stock portfolio, including Cramer's 5 favorites to buy.

Novo Nordisk CEO defends lawsuit against Eli Lilly: 'Competition has to be fair'

Lilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide.

Jim Cramer's top 10 things to watch in the stock market Wednesday.

We're lifting our price target on Cardinal Health after issuing rosy profit guidance.

Eli Lilly takes weight-loss pill battle global with first Foundayo approval outside U.S.

How news affects LLY

Related tickers

Get LLY alerts before the market moves

Frequently asked questions

What is moving LLY today?

How do I get LLY news alerts?